vs
DHT Holdings, Inc.（DHT）与Esperion Therapeutics, Inc.（ESPR）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是DHT Holdings, Inc.的1.6倍（$168.4M vs $107.3M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -24.5%）
DHT控股是一家独立的国际原油运输企业，持有并运营大型原油运输船队，主要服务全球油气行业，为头部石油生产商、炼油厂和大宗商品贸易商提供跨国际核心贸易航线的原油海运服务。
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
DHT vs ESPR — 直观对比
营收规模更大
ESPR
是对方的1.6倍
$107.3M
营收增速更快
ESPR
高出168.2%
-24.5%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $107.3M | $168.4M |
| 净利润 | $44.8M | — |
| 毛利率 | — | — |
| 营业利润率 | 44.2% | 50.6% |
| 净利率 | 41.7% | — |
| 营收同比 | -24.5% | 143.7% |
| 净利润同比 | 27.3% | — |
| 每股收益（稀释后） | $0.28 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHTESPR
| Q4 25 | — | $168.4M | ||
| Q3 25 | $107.3M | $87.3M | ||
| Q2 25 | — | $82.4M | ||
| Q1 25 | — | $65.0M | ||
| Q4 24 | — | $69.1M | ||
| Q3 24 | $142.1M | $51.6M | ||
| Q2 24 | — | $73.8M | ||
| Q1 24 | — | $137.7M |
净利润DHTESPR
| Q4 25 | — | — | ||
| Q3 25 | $44.8M | $-31.3M | ||
| Q2 25 | — | $-12.7M | ||
| Q1 25 | — | $-40.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | $35.2M | $-29.5M | ||
| Q2 24 | — | $-61.9M | ||
| Q1 24 | — | $61.0M |
营业利润率DHTESPR
| Q4 25 | — | 50.6% | ||
| Q3 25 | 44.2% | -11.4% | ||
| Q2 25 | — | 8.6% | ||
| Q1 25 | — | -34.0% | ||
| Q4 24 | — | -6.4% | ||
| Q3 24 | 29.7% | -31.0% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 52.5% |
净利率DHTESPR
| Q4 25 | — | — | ||
| Q3 25 | 41.7% | -35.9% | ||
| Q2 25 | — | -15.4% | ||
| Q1 25 | — | -62.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | 24.8% | -57.2% | ||
| Q2 24 | — | -83.9% | ||
| Q1 24 | — | 44.3% |
每股收益（稀释后）DHTESPR
| Q4 25 | — | $0.32 | ||
| Q3 25 | $0.28 | $-0.16 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | $0.22 | $-0.15 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | — | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $81.3M | $167.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.1B | $-302.0M |
| 总资产 | $1.4B | $465.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DHTESPR
| Q4 25 | — | $167.9M | ||
| Q3 25 | $81.3M | $92.4M | ||
| Q2 25 | — | $86.1M | ||
| Q1 25 | — | $114.6M | ||
| Q4 24 | — | $144.8M | ||
| Q3 24 | $73.8M | $144.7M | ||
| Q2 24 | — | $189.3M | ||
| Q1 24 | — | $226.6M |
股东权益DHTESPR
| Q4 25 | — | $-302.0M | ||
| Q3 25 | $1.1B | $-451.4M | ||
| Q2 25 | — | $-433.5M | ||
| Q1 25 | — | $-426.2M | ||
| Q4 24 | — | $-388.7M | ||
| Q3 24 | $1.0B | $-370.2M | ||
| Q2 24 | — | $-344.2M | ||
| Q1 24 | — | $-294.3M |
总资产DHTESPR
| Q4 25 | — | $465.9M | ||
| Q3 25 | $1.4B | $364.0M | ||
| Q2 25 | — | $347.1M | ||
| Q1 25 | — | $324.0M | ||
| Q4 24 | — | $343.8M | ||
| Q3 24 | $1.5B | $314.1M | ||
| Q2 24 | — | $352.3M | ||
| Q1 24 | — | $373.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.9M | $45.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 1.36× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DHTESPR
| Q4 25 | — | $45.2M | ||
| Q3 25 | $60.9M | $-4.3M | ||
| Q2 25 | — | $-31.4M | ||
| Q1 25 | — | $-22.6M | ||
| Q4 24 | — | $-35.0M | ||
| Q3 24 | $80.1M | $-35.3M | ||
| Q2 24 | — | $-7.2M | ||
| Q1 24 | — | $53.8M |
自由现金流DHTESPR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-35.5M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | — | $53.8M |
自由现金流率DHTESPR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -68.7% | ||
| Q2 24 | — | -9.9% | ||
| Q1 24 | — | 39.0% |
资本支出强度DHTESPR
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
现金转化率DHTESPR
| Q4 25 | — | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.28× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DHT
暂无分部数据
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
